73% of Respondents Had Never Heard of ATTR-CM, a Serious Heart Condition Where Women Face Later Diagnosis, Lower Treatment Rates, And Worse Outcomes
CHICAGO, May 14, 2026 /PRNewswire/ -- Every year, countless women are told their breathlessness is stress, their fatigue is menopause, and their heart symptoms are "something else." For women with ATTR-Cardiac Amyloidosis (ATTR-CM), a serious heart disease that worsens over time, that delay in recognition can mean the difference between early treatment and a life-altering outcome.
This Women's Health Month, BlackDoctor, in collaboration with HealthyWomen and BridgeBio Pharma, Inc., is spotlighting an overlooked issue in women's health: ATTR-CM is not just underdiagnosed — it's systematically missed in women. New survey findings of more than 1,000 respondents reveal that despite high interest in understanding their heart health risk, most Black women have never heard of ATTR-CM, and almost none have ever been screened for it.